Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px
Organisation › Details

WuXi PharmaTech (Group)

The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customerfocused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. *

 

Period Start 2000-12-01 established
Products Industry drug discovery
  Industry 2 chemical compound library (production)
     
Region Region Shanghai
  Country China
  Street 288 Fute Zhong Road, Wai gaoqiao Free Trade Zone
  City 200131 Shanghai
  Tel +86-21-5046-1111
    Address record changed: 2018-07-24
     
Basic data Employees F: 1,001 to 5,000 (2010-05-25)
     
    * Document for �About Section�: Immutep S.A.. (4/8/14). "Press Release: Immutep and Eddingpharm Start Production of ImmuFact IMP321 at WuXi AppTec in China". Orsay & Shanghai.
     
   
Record changed: 2020-01-12

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for WuXi PharmaTech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] No Content Marketing 650x80px




» top